Tirzepatide (Mounjaro) user and patient advocate
On the other hand, the clinical trials on semaglutide (Wegovy) for weight loss have been clear: On average, people taking that medication lose 15% of their body weight over 68 weeks compared to 2.4% of body weight in those taking a placebo
Full Transparency: Clear ingredient lists and rigorous testing protocols
This suggests that DPP-4 inhibitors, which are commonly used for treating type 2 diabetes mellitus (T2DM), may offer therapeutic benefits beyond glycemic control, potentially mitigating bone resorption and reducing fracture risk [23]
Note: Doses above 1.0 mL (100 units) require a 3 mL syringe with an appropriate subcutaneous needle (e.g., 2527G, inch) rather than a standard U100 insulin syringe
+ Swiss medicine regulator warns against purchase of fake Ozempic The Swiss regulator has analysed Lemon Bottle samples injected into adipose tissue (body fat) from various sources